Trials / Completed
CompletedNCT03063099
ReNu™ Injection to Treat Hip Osteoarthritis Study
A Pilot Study of ReNu™ Hip Injection: Monitoring the Response of Hip Function and Pain in Patient With Osteoarthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- NuTech Medical, Inc · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
A pilot study to evaluate changes in hip function and pain in patients with osteoarthritis receiving the ReNu™ Hip Injection.
Detailed description
This is a prospective, non-randomized pilot study evaluating the efficacy of ReNu™ hip injection on patients with moderate osteoarthritis. The effects will be measured primarily through patient-reported outcomes questionnaires after a single injection. Patients will be followed up to 12 months to evaluate improvements using common pain and function subscales.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ReNu™ Injection | Injection into the hip for the treatment of Osteoarthritis. |
Timeline
- Start date
- 2017-02-08
- Primary completion
- 2019-06-28
- Completion
- 2019-06-28
- First posted
- 2017-02-24
- Last updated
- 2020-01-14
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03063099. Inclusion in this directory is not an endorsement.